Erythromycin A enol ether

Erythromycin A enol ether

• CAS Number: 33396-29-1
• UNSPSC Description: Erythromycin A enol ether is an acidic degradation product of Erythromycin A (macrolide antibiotic) and has no antibacterial effect[1][2].
• Target Antigen: Antibiotic
• Type: Reference compound
• Related Pathways: Anti-infection
• Applications: COVID-19-immunoregulation
• Field of Research: Infection
• Assay Protocol: https://www.medchemexpress.com/erythromycin-a-enol-ether.html
• Purity: 98.86
• Solubility: DMSO : 100 mg/mL (ultrasonic)
• Smiles: C[C@@](OC([C@@H]([C@H]([C@](O)1C)O)C)=C2C)(C2)[C@@H]([C@H]([C@@H]([C@H](C(O[C@@H]1CC)=O)C)O[C@H](O[C@H]3C)C[C@](C)([C@H]3O)OC)C)O[C@H](O[C@@H]4C)[C@@H]([C@H](C4)N(C)C)O
• Molecular Weight: 715.91
• References & Citations: [1]A Deubel, et al. Development of an enhanced separation of erythromycin and its related substances by liquid chromatography. J Pharm Biomed Anal. 2007 Jan 17;43(2):493-8.|[2]Abdolreza Hassanzadeh, et al. Mechanism for the degradation of erythromycin A and erythromycin A 2'-ethyl succinate in acidic aqueous solution. J Phys Chem A. 2007 Oct 11;111(40):10098-104.
• Shipping Conditions: Blue Ice
• Storage Conditions: -20°C (Powder, stored under nitrogen)
• Clinical Information: No Development Reported